{"data":[{"accessionNo":"0000919574-26-005208","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Sirenia Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":814801,"percentOfClass":4.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0000919574-26-005208","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Alex Silverstein","reportingCik":null,"personType":"HC,IN","sharesOwned":814801,"percentOfClass":4.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0001167557-26-000168","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"AQR Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":882595,"percentOfClass":5.54,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0001167557-26-000168","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"AQR Capital Management Holdings, LLC","reportingCik":null,"personType":"HC","sharesOwned":882595,"percentOfClass":5.54,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0001104659-26-074154","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-09","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":890366,"percentOfClass":5.6,"filedAt":"2026-06-15","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0001104659-26-074154","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-09","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":890366,"percentOfClass":5.6,"filedAt":"2026-06-15","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0001104659-26-074154","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-09","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":890366,"percentOfClass":5.6,"filedAt":"2026-06-15","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0000919574-26-003212","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Sirenia Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1297470,"percentOfClass":8.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0000919574-26-003212","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Alex Silverstein","reportingCik":null,"personType":"HC,IN","sharesOwned":1297470,"percentOfClass":8.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0000919574-26-003484","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1100964,"percentOfClass":6.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0000919574-26-003484","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":1100964,"percentOfClass":6.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0000919574-26-003484","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":1100964,"percentOfClass":6.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0000102909-26-002406","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp","ticker":"TNXP","cusip":"890260839","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0000102909-26-000297","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp","ticker":"TNXP","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":673605,"percentOfClass":5.02,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0002012383-26-000796","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":854579,"percentOfClass":6.7,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0000902664-25-005443","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-29","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1235058,"percentOfClass":9.2,"filedAt":"2025-12-31","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0000902664-25-005443","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-29","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":1235058,"percentOfClass":9.2,"filedAt":"2025-12-31","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0000902664-25-005443","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-29","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":1235058,"percentOfClass":9.2,"filedAt":"2025-12-31","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0000102909-25-000328","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp","ticker":"TNXP","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":556957,"percentOfClass":6.35,"filedAt":"2025-10-31","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"},{"accessionNo":"0002012383-25-002913","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001430306","issuerName":"Tonix Pharmaceuticals Holding Corp.","ticker":"TNXP","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":680036,"percentOfClass":7.8,"filedAt":"2025-10-17","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp"}],"updatedAt":"2026-10-24T23:20:56.451Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/tnxp","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}